Therapeutic Drug Monitoring in Special Circumstances in Inflammatory Bowel Disease. [PDF]
Povlsen S +4 more
europepmc +1 more source
Hemophagocytic lymphohistiocytosis in patients with inflammatory bowel diseases: a systematic review. [PDF]
Lan T, Luo Q, Guo X, Jiang X.
europepmc +1 more source
Postoperative Recurrence in Crohn's Disease: Pathophysiology, Risk Stratification, and Management Strategies. [PDF]
Bertin L +11 more
europepmc +1 more source
A Rare Presentation of a Devastating Disease: Hepatosplenic T-Cell Lymphoma in Crohn's Disease Without Thiopurine Exposure. [PDF]
Chang M +3 more
europepmc +1 more source
Vedolizumab induced acute interstitial nephritis. [PDF]
Fernandes D +3 more
europepmc +1 more source
Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry. [PDF]
Mañosa M +76 more
europepmc +1 more source
Assessment of Azathioprine-Associated Lymphopenia Incidence Rates in Polish Children with Inflammatory Bowel Disease and Autoimmune Hepatitis: A Retrospective Study. [PDF]
Bąk-Drabik K +7 more
europepmc +1 more source
Managing inflammatory bowel disease in patients receiving cancer-associated chemotherapy and beyond. [PDF]
Ryan-Fisher C +3 more
europepmc +1 more source
Pharmacogenetic Analysis of TPMT and NUDT15 in a European Pediatric Cohort with IBD and Autoimmune Diseases: Frequency Data and Clinical Relevance. [PDF]
Pau A +10 more
europepmc +1 more source
Cancer incidence in patients with ulcerative colitis naïve to or treated with thiopurine and targeted therapies-a cohort study 2007 to 2022 with comparison to the general population. [PDF]
Everhov ÅH +8 more
europepmc +1 more source

